Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
Authors:
- 1 August 2022
- journal article
- research article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 18 (6) , 492-502
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 29 references indexed in Scilit:
- Basics of meta‐analysis: I2 is not an absolute measure of heterogeneityResearch Synthesis Methods, 2017
- Thrombogenicity and Early Vascular Healing Response in Metallic Biodegradable Polymer-Based and Fully Bioabsorbable Drug-Eluting StentsCirculation: Cardiovascular Interventions, 2015
- Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary RevascularizationJACC, 2013
- Role of Endothelial Shear Stress in Stent Restenosis and ThrombosisJACC, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Intracoronary Stenting and Angiographic ResultsCirculation, 2001
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986